chr6-63726614-TGAAAG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001142800.2(EYS):βc.8133_8137delβ(p.Phe2712CysfsTer33) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000367 in 1,551,048 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 32)
Exomes π: 0.000038 ( 0 hom. )
Consequence
EYS
NM_001142800.2 frameshift
NM_001142800.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.35
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
PHF3 (HGNC:8921): (PHD finger protein 3) This gene encodes a member of a PHD finger-containing gene family. This gene may function as a transcription factor and may be involved in glioblastomas development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 63 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-63726614-TGAAAG-T is Pathogenic according to our data. Variant chr6-63726614-TGAAAG-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 558163.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-63726614-TGAAAG-T is described in Lovd as [Likely_pathogenic]. Variant chr6-63726614-TGAAAG-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.8133_8137del | p.Phe2712CysfsTer33 | frameshift_variant | 42/43 | ENST00000503581.6 | NP_001136272.1 | |
EYS | NM_001292009.2 | c.8196_8200del | p.Phe2733CysfsTer33 | frameshift_variant | 43/44 | NP_001278938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.8133_8137del | p.Phe2712CysfsTer33 | frameshift_variant | 42/43 | 5 | NM_001142800.2 | ENSP00000424243 | A2 | |
EYS | ENST00000370621.7 | c.8196_8200del | p.Phe2733CysfsTer33 | frameshift_variant | 43/44 | 1 | ENSP00000359655 | P2 | ||
PHF3 | ENST00000505138.1 | c.363+15256_363+15260del | intron_variant | 3 | ENSP00000421417 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152002Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000586 AC: 9AN: 153540Hom.: 0 AF XY: 0.0000982 AC XY: 8AN XY: 81444
GnomAD3 exomes
AF:
AC:
9
AN:
153540
Hom.:
AF XY:
AC XY:
8
AN XY:
81444
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000379 AC: 53AN: 1399046Hom.: 0 AF XY: 0.0000435 AC XY: 30AN XY: 690044
GnomAD4 exome
AF:
AC:
53
AN:
1399046
Hom.:
AF XY:
AC XY:
30
AN XY:
690044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152002Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74240
GnomAD4 genome
AF:
AC:
4
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74240
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Retinitis pigmentosa 25 Pathogenic:6
Pathogenic, criteria provided, single submitter | research | Ocular Genomics Institute, Massachusetts Eye and Ear | Apr 08, 2021 | The EYS c.8133_8137del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM3. Based on this evidence we have classified this variant as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 22, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 02, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 12, 2018 | The EYS c.8133_8137delCTTTC; p.Phe2712fs variant (rs751629543), also known as c.8196_8200delCTTTC p.F2733Cfs*33 based on NM_001292009.1, is published in the medical literature in a family with autosomal recessive retinitis pigmentosa (Arai 2015). The variant is listed in the ClinVar database (Variation ID: 558163) and in the general population with an allele frequency of 0.006% (9/148188 alleles) in the Genome Aggregation Database. This variant causes a frameshift by deleting 5 nucleotides so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, this variant is predicted to cause loss of a critical functional domain (Hosono 2012). Considering available information, this variant is predicted to be pathogenic. References: Arai Y et al. Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations. J Ophthalmol. 2015;2015:819760 Hosono K et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One. 2012;7(2):e31036 - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 22, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals | Feb 01, 2019 | - - |
Autosomal recessive retinitis pigmentosa Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This sequence change creates a premature translational stop signal (p.Phe2712Cysfs*33) in the EYS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 433 amino acid(s) of the EYS protein. This variant is present in population databases (rs751629543, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 26161267, 30153090). ClinVar contains an entry for this variant (Variation ID: 558163). This variant disrupts a region of the EYS protein in which other variant(s) (p.Thr3038Ilefs*4 and p.Asn3061Thrfs*3) have been determined to be pathogenic (PMID: 20333770, 21069908). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at